Core Insights - SS Innovations International, Inc. reported a significant revenue increase of 192.5% year-over-year, reaching $12.8 million in Q3 2025, primarily driven by higher sales of the SSi Mantra 3 surgical robotic system [1][6][11] Financial Performance - Q3 2025 revenue rose to $12.8 million from $4.4 million in Q3 2024, with a gross profit increase of 166.0% to $6.2 million [6][11] - Gross margin for Q3 2025 was 48.1%, down from 52.8% in Q3 2024 [6] - The net loss for Q3 2025 was $3.7 million, consistent with the net loss of $3.2 million in Q3 2024 [6][11] - For the first nine months of 2025, total revenue increased by 123.0% to $28.0 million compared to $12.5 million in the same period of 2024 [6][8] - Cumulative surgeries performed using the SSi Mantra reached 6,057, including 56 telesurgeries and 319 cardiac procedures [6][12] Business Highlights - The number of SSi Mantra installations in Q3 2025 totaled 27, a 350.0% increase from 6 installations in Q3 2024 [6][11] - The cumulative installed base of SSi Mantra systems reached 127 across seven countries [6][11] - The company has received regulatory approval for the SSi Mantra in seven countries and is preparing to enter the U.S. and European Union markets [4][12] Upcoming Developments - The company plans to submit a 510(k) premarket notification to the FDA in Q4 2025 and aims for CE marking certification in the EU in the first half of 2026 [4][12] - SS Innovations is scheduled to participate in investor conferences in November 2025, providing opportunities for management to engage with investors [9][10]

Core Insights - SS Innovations International, Inc. is focused on developing innovative surgical robotic technologies to make robotic surgery affordable and accessible globally [2][5] - The company will participate in upcoming investor conferences, including the UBS Global Healthcare Conference and the Stifel 2025 Healthcare Conference [3][4] Company Overview - SS Innovations is headquartered in India and aims to expand its global presence with cost-effective surgical robotic solutions [5] - The company's product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures, including robotic cardiac surgery [5] Product Performance - As of September 30, 2025, the SSi Mantra has a cumulative installed base of 125 systems across six countries, with 119 hospitals having installed the system [6] - Over 6,000 surgical procedures have been performed using the SSi Mantra, including 60 telesurgeries and 310 cardiac procedures [6] Product Features - The SSi Mantra is a modular, multi-arm surgical robotic system featuring advanced technology such as 3 to 5 robotic arms, a 3D 4K monitor, and a virtual real-time image display [7] - It utilizes over 40 different types of robotic endo-surgical instruments and has been clinically validated in India for more than 100 different types of surgical procedures [8]

Core Insights - SS Innovations International, Inc. is focused on developing innovative surgical robotic technologies to enhance the accessibility and affordability of robotic surgery globally [4][5]. Company Overview - SS Innovations is headquartered in India and aims to expand its global presence with its advanced and cost-effective surgical robotic solutions [4]. - The company’s product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which cater to various surgical procedures, including robotic cardiac surgery [4]. Recent Developments - As of September 30, 2025, the SSi Mantra has a cumulative installed base of 125 systems across six countries, with 119 hospitals utilizing the system [5]. - Over 6,000 surgical procedures have been performed using the SSi Mantra, which includes 60 telesurgeries and 310 cardiac procedures [5]. Upcoming Events - Dr. Sudhir Srivastava and Dr. Vishwa Srivastava will participate in the UBS Global Healthcare Conference on November 11, 2025, and the Stifel 2025 Healthcare Conference on November 12, 2025 [2][3]. - The Stifel conference will feature a group presentation at 4:40 p.m. Eastern Time, with a live webcast available on the company’s website [3]. Product Features - The SSi Mantra is a modular, multi-arm surgical robotic system equipped with advanced technology features, including 3 to 5 robotic arms, a 3D 4K monitor, and a virtual real-time imaging capability [6]. - It supports over 40 different types of robotic endo-surgical instruments, validated in more than 100 types of surgical procedures in India [6].

Core Insights - SS Innovations International, Inc. has successfully completed a human factors validation study for its SSi Mantra surgical robotic system at Johns Hopkins Hospital, marking a significant milestone in its regulatory process [1][2] - The company plans to submit a 510(k) premarket notification to the FDA in the fourth quarter of 2025, aiming for potential market clearance in the first half of 2026 [1][3] - The SSi Mantra has a cumulative installed base of 125 systems across six countries, with over 6,000 surgical procedures performed to date [4] Company Overview - SS Innovations is focused on developing innovative surgical robotic technologies to make robotic surgery more affordable and accessible globally [5] - The SSi Mantra system features a modular design with advanced technology, including multiple robotic arms and a 3D 4K monitor, supporting various surgical specialties [6] Regulatory Pathway - The company has shifted from a De Novo request to a 510(k) regulatory pathway, which is expected to provide speed and cost advantages in the approval process [4] - RQM+, a MedTech-focused CRO, has been engaged to assist with the 510(k) submission [2]

Company Overview - SS Innovations International, Inc. (NASDAQ:SSII) is focused on advancing affordable surgical robotics with its flagship SSi Mantra system, which provides a cost-efficient alternative to established platforms like Intuitive Surgical's da Vinci [2] - The SSi Mantra system has received approval in seven countries, including India, Indonesia, and the Philippines, and the company is seeking regulatory approval in the U.S. and Europe to expand its market presence [2] Financial Performance - In Q2 2025, SS Innovations International, Inc. reported a revenue increase of 121.8% to $10 million, with gross profit more than tripling year-over-year [4] - The installations of the SSi Mantra system grew by 130% year-over-year, resulting in a total installed base of 105 systems that have performed 4,657 surgeries as of June 30, 2025 [4] Leadership Changes - Naveen Kumar Amar was appointed as Chief Financial Officer in September 2025, bringing extensive international finance experience as the company prepares for increased sales and regulatory submissions [3] Technological Achievements - The company achieved a significant milestone by performing the world's first intercontinental robotic cardiac telesurgery in July 2025, showcasing its advanced technological capabilities [4]

Core Viewpoint - SS Innovations International, Inc. has appointed Naveen Kumar Amar as Chief Financial Officer, effective September 24, 2025, succeeding Dr. Vishwa Srivastava, who will continue as CEO for Asia Pacific [1][2]. Company Overview - SS Innovations is focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [6]. - The company’s product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures, including robotic cardiac surgery [6][9]. Leadership Experience - Naveen Kumar Amar brings over 25 years of global finance leadership experience across various industries and geographies, with expertise in financial accounting, planning, corporate finance, and governance [2][4]. - Amar has previously held significant positions, including Head of Finance & Commercial for SpiceXpress and Global CFO for Munch Ado India Private Ltd. [4]. Strategic Vision - The appointment of Amar is seen as a strategic move to enhance the financial operations of SS Innovations as the company aims to expand its global presence with the SSi Mantra surgical robotic system [3]. - Amar expressed his commitment to driving growth and delivering sustainable long-term shareholder value for SS Innovations [3].

Core Viewpoint - SS Innovations International, Inc. has appointed Naveen Kumar Amar as the new Chief Financial Officer, effective September 24, 2025, succeeding Dr. Vishwa Srivastava, who will continue as CEO for Asia Pacific [1][2][3]. Company Overview - SS Innovations is focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [5]. - The company’s product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures, including robotic cardiac surgery [5]. Leadership Appointment - Naveen Kumar Amar brings over 25 years of global finance leadership experience across various industries and geographies, with expertise in financial accounting, reporting, planning, analysis, and corporate finance [2][3]. - Amar has previously held significant positions, including Global CFO for Munch Ado India Private Ltd. and Head of Finance & Commercial for SpiceXpress [2][3]. Strategic Vision - The company aims to expand the global presence of its advanced, cost-efficient surgical robotic systems, particularly the SSi Mantra [3]. - Amar expressed his commitment to democratizing access to advanced surgical robotic care and driving growth to deliver sustainable long-term shareholder value [3]. Product Details - The SSi Mantra surgical robotic system features a modular design with 3 to 5 robotic arms, an ergonomic surgeon command center, and advanced imaging capabilities [6]. - It has been clinically validated in India for over 100 different types of surgical procedures, showcasing its versatility and effectiveness [6].

Core Insights - SS Innovations has successfully completed the world's first pediatric pyeloplasty telesurgery using its SSi Mantra surgical robotic system, demonstrating the system's capabilities in remote surgical procedures [2][3][5]. Company Overview - SS Innovations International, Inc. focuses on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [6]. - The company is headquartered in India and plans to expand its global presence with cost-effective surgical robotic solutions [6]. Product Details - The SSi Mantra surgical robotic system features a modular design with 3 to 5 robotic arms, an ergonomic command center, and advanced imaging capabilities, supporting various surgical specialties including pediatric surgery [7]. - The system has been clinically validated in over 100 different types of surgical procedures in India [7]. Market Opportunity - SS Innovations aims to address the unmet surgical robotic needs in the growing pediatric market, aligning with its mission to provide world-class care to underserved communities [5]. - The company has performed more than 50 telesurgeries at distances of up to 4,000 miles, showcasing the potential of the SSi Mantra in reaching remote patients [5]. Leadership Perspective - The Chairman and CEO of SS Innovations emphasized the advantages of robotic surgery, including precision, less invasiveness, and quicker recovery times, particularly important in pediatric care [3].

Core Insights - SS Innovations International, Inc. has successfully performed the world's first pediatric pyeloplasty telesurgery using its SSi Mantra surgical robotic system, demonstrating the system's capabilities in remote surgical procedures [1][3] - The SSi Mantra system is designed to make robotic surgery more precise, less invasive, and quicker, which is particularly beneficial in pediatric surgery [3] - The company aims to address the unmet needs in the growing pediatric surgical market by expanding the capabilities of the SSi Mantra system [4] Company Overview - SS Innovations develops innovative surgical robotic technologies with a mission to make robotic surgery affordable and accessible globally [5][6] - The SSi Mantra system features advanced technology, including modular robotic arms and a 3D 4K monitor, and has been clinically validated for over 100 different types of surgical procedures [7] Market Opportunity - The company is focusing on expanding its presence in the pediatric market, which is seen as a significant growth area for surgical robotics [4] - More than 50 telesurgeries have been performed using the SSi Mantra system, showcasing its versatility across various surgical categories [3]

Core Viewpoint - SS Innovations International, Inc. has successfully completed its first robotic telesurgery using the MantraM mobile robotic telesurgery unit, marking a significant milestone in making advanced surgical robotic care accessible to underserved populations [1][3]. Company Overview - SS Innovations is focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally [5]. - The company’s product offerings include the proprietary "SSi Mantra" surgical robotic system and the "SSi Mudra" surgical instruments, which support various surgical procedures, including robotic cardiac surgery [5]. Technological Advancements - The SSi Mantra surgical robotic system features a modular design with 3 to 5 robotic arms, an ergonomic command center, and advanced imaging capabilities, including a 3D 4K monitor [6]. - The system has been clinically validated in over 100 different types of surgical procedures in India, showcasing its versatility and effectiveness [6]. Recent Developments - In July 2025, SS Innovations launched a MantraM bus tour across India to demonstrate the capabilities of its mobile robotic telesurgery unit and the SSi Mantra system, focusing on underserved communities [3]. - The first robotic telesurgery was guided by Dr. Priya Bhave Chittawar from the MantraM bus, connecting to an operating room in Bhopal, India, highlighting the system's remote surgical capabilities [1][3]. Mission and Vision - The company aims to democratize access to high-quality surgical robotic care and education, particularly in remote settings, by overcoming traditional cost and distance barriers [3]. - The MantraM bus is designed not only to provide specialized care but also to facilitate surgical education and training for medical professionals [3].